HSBC Holdings’s Outset Medical OM Stock Holding History

HSBC Holdings’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,322	Closed	-$45.6K	–	3133
2025 Q4	$45.6K	Buy	+12,322	New	+$106K	﹤0.01%	2870

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HSBC Holdings's OM Position: Q1 2026 in Review

HSBC Holdings sold out of Outset Medical (OM) in Q1 2026, closing a stake of 12,322 shares — an estimated $45.6K sold.

HSBC Holdings first reported a position in OM in Q4 2025 and held it in 1 quarter. The position peaked at $45.6K in Q4 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

HSBC Holdings reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
HSBC Holdings sold 12,322 Outset Medical shares in Q1 2026, an estimated $45.6K.
HSBC Holdings first reported a position in Outset Medical in Q4 2025 and held it in 1 quarter.
HSBC Holdings's Outset Medical position peaked at $45.6K in Q4 2025.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.